AKT inhibitor

Related by string. Akt inhibitor * Akter . Akt : inhibits Akt activation . AKT BCR ABL BRAF . kinase PI3K Akt pathway . modulates Akt . modulates Akt protein . Taslima Akter / Inhibitor . Inhibitors . inhibitors : proton pump inhibitors . proton pump inhibitors PPIs . small molecule inhibitor . proton pump inhibitor PPI . ACE inhibitors . Proton Pump Inhibitors PPIs * active AKT inhibitor *

Related by context. Frequent words. (Click for all words.) 75 liposomal formulation 72 orally bioavailable 71 proteasome inhibitor 71 multi kinase inhibitor 71 Daclizumab 70 MEK inhibitor 70 targeting CD# 70 Tesetaxel 70 Phase Ib clinical 69 kinase inhibitor 69 ATL# [001] 69 proteasome inhibitors 69 PSN# [002] 69 Phase Ib II 69 MKC# 69 Initiate Phase 69 vascular disrupting agent 69 Epratuzumab 69 anticancer compound 69 AEG# 68 polymerase inhibitor 68 TLR9 agonist 68 Panzem R 68 PEG SN# 68 Factor VIIa 68 Irinotecan 68 forodesine 68 GRNVAC1 68 talabostat 68 Bortezomib 68 Guanilib 67 selective inhibition 67 IMC #B 67 Voreloxin 67 novel orally administered 67 enzyme inhibitor 67 refractory chronic lymphocytic 67 humanized anti 67 CYC# 67 radiolabeled 67 BMS # 67 EZN 67 hypoxia inducible factor 67 antiangiogenic 67 selectively inhibits 66 xenograft models 66 elotuzumab 66 tyrosine kinase inhibitor 66 PEGPH# 66 angiogenesis inhibitor 66 renin inhibitors 66 REOLYSIN ® 66 CD# expressing 66 Mipomersen 66 DDP# 66 oral candidiasis 66 anti mitotic 66 nucleoside reverse transcriptase inhibitor 66 pertuzumab 66 Denufosol 66 Dapagliflozin 66 Aurora kinase 66 small molecule inhibitor 66 immune modulator 66 R sorafenib tablets 66 prodrugs 66 Golimumab 66 PXD# 66 Azedra 66 multiple myeloma MM 66 Drug Candidate 66 phase IIb clinical 66 ThermoDox R 66 CCX# 66 nitric oxide donating 66 castrate resistant prostate cancer 66 immunomodulator 65 Pivotal Phase III 65 BZL# 65 Dasatinib 65 PEP# [003] 65 Bavituximab 65 immunomodulating 65 liposomal 65 enzastaurin 65 novel anticancer 65 Perifosine 65 siRNA therapeutics 65 relapsed refractory multiple myeloma 65 Nanobody 65 Hsp# inhibitors 65 SAR# [004] 65 KRN# 65 HER2 positive metastatic breast 65 therapeutic monoclonal antibodies 65 anti fibrotic 65 phase IIa clinical 65 drug conjugate 65 CA4P 65 humanized monoclonal antibody 65 phase Ib

Back to home page